These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 22191238)

  • 41. Natural cytotoxicity against mouse hepatitis virus-infected target cells. I. Correlation of cytotoxicity with virus binding to leukocytes.
    Holmes KV; Welsh RM; Haspel MV
    J Immunol; 1986 Feb; 136(4):1446-53. PubMed ID: 3003198
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immortalized fibroblasts from NF-kappaB RelA knockout mice show phenotypic heterogeneity and maintain increased sensitivity to tumor necrosis factor alpha after transformation by v-Ras.
    Gapuzan ME; Schmah O; Pollock AD; Hoffmann A; Gilmore TD
    Oncogene; 2005 Sep; 24(43):6574-83. PubMed ID: 16027734
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of the Na(+)/K(+)/Cl(-) cotransporter gene induces cell proliferation and phenotypic transformation in mouse fibroblasts.
    Panet R; Marcus M; Atlan H
    J Cell Physiol; 2000 Jan; 182(1):109-18. PubMed ID: 10567922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of melatonin on mitosis of the mouse ascites hepatoma Gelstein 22A].
    Vasil'ev SV
    Biull Eksp Biol Med; 1979 Nov; 88(11):595-6. PubMed ID: 540154
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Target-induced changes in macrophage migration may explain differences in lytic sensitivity among simian virus 40-transformed fibroblasts.
    Laster SM; Wood JG; Gooding LR
    J Immunol; 1988 Jul; 141(1):221-7. PubMed ID: 2837509
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity.
    Bright RK; Shearer MH; Kennedy RC
    J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Neoplastic progression by EJ/ras at different steps of transformation in vitro of human uroepithelial cells.
    Pratt CI; Kao CH; Wu SQ; Gilchrist KW; Oyasu R; Reznikoff CA
    Cancer Res; 1992 Feb; 52(3):688-95. PubMed ID: 1310069
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of tumor metastasis and suppression of natural killer cell activity by beta-estradiol treatment.
    Hanna N; Schneider M
    J Immunol; 1983 Feb; 130(2):974-80. PubMed ID: 6848604
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lenalidomide down regulates the production of interferon-gamma and the expression of inhibitory cytotoxic receptors of human Natural Killer cells.
    Dauguet N; Fournié JJ; Poupot R; Poupot M
    Cell Immunol; 2010; 264(2):163-70. PubMed ID: 20621290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Restoration of growth control in malignantly transformed mouse fibroblasts grown in a chemically defined medium.
    Tomei LD; Bertram JS
    Cancer Res; 1978 Feb; 38(2):444-51. PubMed ID: 620413
    [TBL] [Abstract][Full Text] [Related]  

  • 52. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
    Piontek GE; Taniguchi K; Ljunggren HG; Grönberg A; Kiessling R; Klein G; Kärre K
    J Immunol; 1985 Dec; 135(6):4281-8. PubMed ID: 3905967
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Influence of the deprivation of a single amino acid on cellular proliferation and survival in rat 3Y1 fibroblasts and their derivatives transformed by a wide variety of agents.
    Tanaka H; Zaitsu H; Onodera K; Kimura G
    J Cell Physiol; 1988 Sep; 136(3):421-30. PubMed ID: 2844831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [CELLS FORM AND THEIR SENSITIVITY TO LYTIC ACTIVITY OF NATURAL KILLER CELLS UNDER THE ANTIOXIDANT ACTION].
    Kirpichnikova KM; Petrov YP; Filatova NA; Gamaley IA
    Tsitologiia; 2015; 57(8):578-83. PubMed ID: 26591569
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Melatonin's growth-inhibitory effect on hepatoma AH 130 in the rat.
    Cini G; Coronnello M; Mini E; Neri B
    Cancer Lett; 1998 Mar; 125(1-2):51-9. PubMed ID: 9566696
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New insights into melatonin regulation of cancer growth.
    Blask DE; Sauer LA; Dauchy RT; Holowachuk EW; Ruhoff MS
    Adv Exp Med Biol; 1999; 460():337-43. PubMed ID: 10810531
    [No Abstract]   [Full Text] [Related]  

  • 58. Control of protein degradation and growth phase in normal and neoplastic cells.
    Baccino FM; Tessitore L; Bonelli G
    Toxicol Pathol; 1984; 12(3):281-7. PubMed ID: 6515280
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Changes of cell surface configuration and regulation of cell proliferation.
    Adam G; Walz U
    Biophys Struct Mech; 1975 Dec; 1(4):329-32. PubMed ID: 184860
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Induction of phenotypic reverse transformation by ginsenosides in cultured Morris hepatoma cells.
    Odashima S; Nakayabu Y; Honjo N; Abe H; Arichi S
    Eur J Cancer (1965); 1979 Jun; 15(6):885-92. PubMed ID: 227695
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.